50
Participants
Start Date
October 31, 2014
Primary Completion Date
October 31, 2016
Study Completion Date
March 31, 2017
CMV/EBV specific T-cell
Peptide stimulated allogeneic T-cells with dual specificity for CMV and EBV
Charité University Hospital Berlin, Berlin
University of Mainz, Mainz
University of Munich LMU, Munich
Medical Center Augsburg, Augsburg
Universitiy Hospital Erlangen, Erlangen
University of Regensburg, Regensburg
Collaborators (1)
Ludwig-Maximilians - University of Munich
OTHER
University of Regensburg
OTHER
Johannes Gutenberg University Mainz
OTHER
Charite University, Berlin, Germany
OTHER
University Hospital Augsburg
OTHER
BayImmuNet Bavarian Immunotherapy Network
UNKNOWN
German Research Foundation
OTHER
University of Erlangen-Nürnberg Medical School
OTHER